title: The Role of Heparanase and Sulfatases in the Modification of Heparan Sulfate Proteoglycans within the Tumor Microenvironment and Opportunities for Novel Cancer Therapeutics.
abstract: Heparan sulfate proteoglycans (HSPGs) are an integral and dynamic part of normal tissue architecture at the cell surface and within the extracellular matrix. The modification of HSPGs in the tumor microenvironment is known to result not just in structural but also functional consequences, which significantly impact cancer progression. As substrates for the key enzymes sulfatases and heparanase, the modification of HSPGs is typically characterized by the degradation of heparan sulfate (HS) chains/sulfation patterns via the endo-6-O-sulfatases (Sulf1 and Sulf2) or by heparanase, an endo-glycosidase that cleaves the HS polymers releasing smaller fragments from HSPG complexes. Numerous studies have demonstrated how these enzymes actively influence cancer cell proliferation, signaling, invasion, and metastasis. The activity or expression of these enzymes has been reported to be modified in a variety of cancers. Such observations are consistent with the degradation of normal architecture and basement membranes, which are typically compromised in metastatic disease. Moreover, recent studies elucidating the requirements for these proteins in tumor initiation and progression exemplify their importance in the development and progression of cancer. Thus, as the influence of the tumor microenvironment in cancer progression becomes more apparent, the focus on targeting enzymes that degrade HSPGs highlights one approach to maintain normal tissue architecture, inhibit tumor progression, and block metastasis. This review discusses the role of these enzymes in the context of the tumor microenvironment and their promise as therapeutic targets for the treatment of cancer.
authors.affiliation: Progen Pharmaceuticals Ltd. , Brisbane, QLD , Australia.
authors.forename: Edward
authors.initials: E
authors.lastname: Hammond
authors.affiliation: Department of Experimental Pathology, Mayo Clinic College of Medicine , Rochester, MN , USA.
authors.forename: Ashwani
authors.initials: A
authors.lastname: Khurana
authors.affiliation: Department of Experimental Pathology, Mayo Clinic College of Medicine , Rochester, MN , USA.
authors.forename: Viji
authors.initials: V
authors.lastname: Shridhar
authors.affiliation: Progen Pharmaceuticals Ltd. , Brisbane, QLD , Australia.
authors.forename: Keith
authors.initials: K
authors.lastname: Dredge
keywords: Sulf1; Sulf2; cancer therapy; heparan sulfate; heparanase; tumor microenvironment targeting
references.citation: Invest New Drugs. 2010 Jun;28(3):276-83
references.pmid: 19357810
references.citation: J Biol Chem. 2008 Jun 27;283(26):18167-76
references.pmid: 18450756
references.citation: Bioorg Med Chem Lett. 2005 May 2;15(9):2295-9
references.pmid: 15837312
references.citation: Med Hypotheses. 2007;68(1):162-5
references.pmid: 16890383
references.citation: J Biol Chem. 2013 Apr 5;288(14):10093-10099
references.pmid: 23430739
references.citation: APMIS. 2010 Nov;118(11):855-63
references.pmid: 20955458
references.citation: J Biol Chem. 2009 Aug 7;284(32):21505-14
references.pmid: 19520866
references.citation: Br J Cancer. 2002 Apr 22;86(8):1270-5
references.pmid: 11953884
references.citation: Blood. 2000 Nov 1;96(9):3139-46
references.pmid: 11049995
references.citation: FEBS Open Bio. 2013 Aug 02;3:346-51
references.pmid: 24251094
references.citation: Leukemia. 2014 Nov;28(11):2178-87
references.pmid: 24699306
references.citation: Cancer. 2006 Feb 1;106(3):532-40
references.pmid: 16388520
references.citation: Cancer Res. 2001 Jun 15;61(12):4655-9
references.pmid: 11406531
references.citation: Expert Opin Ther Targets. 2010 Sep;14(9):935-49
references.pmid: 20629619
references.citation: BMJ Open. 2012 Nov 23;2(6):
references.pmid: 23180455
references.citation: Histopathology. 2010 Jul;57(1):90-100
references.pmid: 20653782
references.citation: Biochem J. 1998 Mar 15;330 ( Pt 3):1341-50
references.pmid: 9494105
references.citation: Cancer Res. 2006 Sep 1;66(17):8779-87
references.pmid: 16951194
references.citation: Int J Mol Med. 2013 May;31(5):1234-42
references.pmid: 23467544
references.citation: PLoS One. 2011;6(6):e21106
references.pmid: 21698156
references.citation: Am J Clin Pathol. 2010 Aug;134(2):242-8
references.pmid: 20660327
references.citation: J Antibiot (Tokyo). 2004 Feb;57(2):136-42
references.pmid: 15112962
references.citation: Biochim Biophys Acta. 2014 Aug;1840(8):2599-608
references.pmid: 24747732
references.citation: Blood. 2002 Feb 15;99(4):1405-10
references.pmid: 11830493
references.citation: Biochem Biophys Res Commun. 2007 Oct 5;361(4):829-34
references.pmid: 17689495
references.citation: Cancer Sci. 2013 Sep;104(9):1189-97
references.pmid: 23786209
references.citation: Development. 2007 Sep;134(18):3327-38
references.pmid: 17720696
references.citation: Clin Cancer Res. 2005 Apr 15;11(8):2899-906
references.pmid: 15837740
references.citation: Br J Cancer. 2011 Feb 15;104(4):635-42
references.pmid: 21285983
references.citation: J Cell Mol Med. 2007 May-Jun;11(3):427-52
references.pmid: 17635638
references.citation: Cancer Microenviron. 2012 Aug;5(2):115-32
references.pmid: 21811836
references.citation: J Cell Mol Med. 2011 Sep;15(9):1857-64
references.pmid: 21029368
references.citation: Med Oncol. 2013;30(3):633
references.pmid: 23794232
references.citation: Proteins. 2006 Nov 15;65(3):580-92
references.pmid: 16972282
references.citation: FEBS J. 2013 May;280(10):2294-306
references.pmid: 23374281
references.citation: J Biol Chem. 2002 Dec 20;277(51):49175-85
references.pmid: 12368295
references.citation: Blood. 2010 Mar 25;115(12):2449-57
references.pmid: 20097882
references.citation: Nat Med. 2006 Apr;12(4):410-6
references.pmid: 16532004
references.citation: BMC Biochem. 2006 Jan 17;7:2
references.pmid: 16417632
references.citation: Tumour Biol. 2012 Oct;33(5):1327-34
references.pmid: 22488243
references.citation: J Biol Chem. 2014 Apr 11;289(15):10488-10501
references.pmid: 24563483
references.citation: Neoplasia. 2006 Dec;8(12):1055-61
references.pmid: 17217623
references.citation: Acta Pharmacol Sin. 2009 Jul;30(7):1033-8
references.pmid: 19543297
references.citation: J Biol Chem. 2005 Dec 2;280(48):40066-73
references.pmid: 16192265
references.citation: Gastroenterology. 2006 Jun;130(7):2130-44
references.pmid: 16762634
references.citation: PLoS One. 2007 Apr 25;2(4):e392
references.pmid: 17460759
references.citation: Asian Pac J Cancer Prev. 2012;13(2):641-6
references.pmid: 22524839
references.citation: Cancer Res. 2009 Jun 1;69(11):4843-50
references.pmid: 19487294
references.citation: Gastroenterology. 2004 Jan;126(1):231-48
references.pmid: 14699503
references.citation: BMC Cancer. 2013 Jan 17;13:24
references.pmid: 23327652
references.citation: Bioorg Med Chem Lett. 2004 Jun 21;14(12):3269-73
references.pmid: 15149688
references.citation: PLoS One. 2012;7(12):e52175
references.pmid: 23300607
references.citation: Leukemia. 2002 Mar;16(3):376-81
references.pmid: 11896541
references.citation: Neoplasia. 2006 Jul;8(7):596-606
references.pmid: 16867222
references.citation: J Biol Chem. 1998 Sep 4;273(36):22936-42
references.pmid: 9722514
references.citation: Int J Cancer. 2014 Oct 15;135(8):1783-9
references.pmid: 24596063
references.citation: Hepatology. 2010 Nov;52(5):1680-9
references.pmid: 20725905
references.citation: Blood. 2007 Jun 1;109(11):4914-23
references.pmid: 17339423
references.citation: Front Oncol. 2013 Dec 19;3:310
references.pmid: 24392351
references.citation: Rambam Maimonides Med J. 2011 Jan 31;2(1):e0019
references.pmid: 23908791
references.citation: J Biochem. 2002 Jun;131(6):913-22
references.pmid: 12038989
references.citation: Clin Exp Metastasis. 2013 Apr;30(4):407-15
references.pmid: 23412907
references.citation: Biochem Pharmacol. 2014 May 1;89(1):12-9
references.pmid: 24565907
references.citation: Carbohydr Res. 2002 Feb 5;337(2):139-46
references.pmid: 11814445
references.citation: World J Surg Oncol. 2014 Apr 25;12:121
references.pmid: 24766948
references.citation: Pathol Int. 2010 Apr;60(4):268-77
references.pmid: 20403028
references.citation: Cancer Res. 2004 Jun 1;64(11):3928-33
references.pmid: 15173004
references.citation: Commun Integr Biol. 2014 Jan 1;7(1):e28231
references.pmid: 24778765
references.citation: Cancer Rep. 2011;1(1):14-19
references.pmid: 22563565
references.citation: Biochemistry. 2000 Dec 26;39(51):15659-67
references.pmid: 11123890
references.citation: Cancer Res. 1999 Jul 15;59(14):3433-41
references.pmid: 10416607
references.citation: Leukemia. 2007 Nov;21(11):2296-303
references.pmid: 17611567
references.citation: J Biol Chem. 2012 Oct 5;287(41):34836-43
references.pmid: 22893710
references.citation: Biochem Biophys Res Commun. 2010 Jan 1;391(1):107-12
references.pmid: 19900405
references.citation: Clin Cancer Res. 2011 Mar 15;17(6):1382-93
references.pmid: 21257720
references.citation: Breast Cancer Res. 2012 Mar 12;14(2):R43
references.pmid: 22410125
references.citation: Nat Genet. 2000 Jul;25(3):329-32
references.pmid: 10888884
references.citation: Hum Pathol. 2014 Apr;45(4):674-82
references.pmid: 24656090
references.citation: Cancer Lett. 2013 Sep 1;337(2):226-36
references.pmid: 23684551
references.citation: Bone. 2013 Nov;57(1):10-7
references.pmid: 23895995
references.citation: J Biol Chem. 2007 May 18;282(20):14906-15
references.pmid: 17344212
references.citation: Exp Cell Res. 2009 Oct 1;315(16):2752-64
references.pmid: 19577565
references.citation: J Biol Chem. 2005 May 27;280(21):20457-66
references.pmid: 15760902
references.citation: Bioorg Med Chem Lett. 2006 Jan 15;16(2):409-12
references.pmid: 16246560
references.citation: PLoS One. 2013 May 21;8(5):e64186
references.pmid: 23704979
references.citation: Clin Cancer Res. 2001 May;7(5):1299-305
references.pmid: 11350898
references.citation: J Transl Med. 2011 May 21;9:72
references.pmid: 21599997
references.citation: Zhonghua Wai Ke Za Zhi. 2008 Oct 1;46(19):1502-4
references.pmid: 19094632
references.citation: Oncol Rep. 2010 Jan;23(1):255-61
references.pmid: 19956890
references.citation: Front Oncol. 2014 Feb 03;4:4
references.pmid: 24551591
references.citation: Int J Oncol. 2012 Oct;41(4):1504-12
references.pmid: 22825572
references.citation: J Exp Clin Cancer Res. 2014 May 10;33:39
references.pmid: 24887057
references.citation: J Clin Invest. 2012 Mar;122(3):911-22
references.pmid: 22293178
references.citation: Carcinogenesis. 2014 Jul;35(7):1491-9
references.pmid: 24445144
references.citation: Biochim Biophys Acta. 2014 Jan;1841(1):108-20
references.pmid: 24140720
references.citation: Cancer Res. 2003 Dec 15;63(24):8614-22
references.pmid: 14695172
references.citation: J Surg Oncol. 2005 May 1;90(2):59-65
references.pmid: 15844185
references.citation: Biopolymers. 2012 Jan;97(1):21-34
references.pmid: 21780097
references.citation: Curr Cancer Drug Targets. 2014;14(3):286-93
references.pmid: 24568197
references.citation: Genes Chromosomes Cancer. 2011 Feb;50(2):122-35
references.pmid: 21104785
references.citation: J Biol Chem. 2007 May 11;282(19):14413-20
references.pmid: 17363371
references.citation: Cancer Microenviron. 2012 Dec;5(3):323-32
references.pmid: 22585423
references.citation: Anticancer Res. 2011 Oct;31(10):3423-8
references.pmid: 21965756
references.citation: Am J Cancer Res. 2013;3(1):34-45
references.pmid: 23359864
references.citation: J Biol Chem. 2008 Nov 21;283(47):32628-36
references.pmid: 18812315
references.citation: Genes Chromosomes Cancer. 2013 Mar;52(3):225-36
references.pmid: 23109092
references.citation: Bioorg Med Chem Lett. 2006 Jan 15;16(2):404-8
references.pmid: 16246551
references.citation: Hepatol Res. 2013 May;43(5):516-25
references.pmid: 22900980
references.citation: J Transl Med. 2012 Oct 24;10:213
references.pmid: 23095131
references.citation: J Cell Physiol. 2014 Nov;229(11):1647-59
references.pmid: 24610459
references.citation: J Cell Biol. 2006 Sep 25;174(7):1097-106
references.pmid: 16982797
references.citation: Cancer Res. 2006 Jun 15;66(12):6025-32
references.pmid: 16778174
references.citation: Front Oncol. 2014 Jan 14;3:331
references.pmid: 24459635
references.citation: J Biol Chem. 2002 Nov 8;277(45):42488-95
references.pmid: 12213822
references.citation: Oncogene. 2005 Jun 9;24(25):4037-51
references.pmid: 15806157
references.citation: World J Gastroenterol. 2004 Oct 1;10(19):2795-9
references.pmid: 15334672
references.citation: Glycobiology. 2012 Jan;22(1):35-55
references.pmid: 21746763
references.citation: Lab Invest. 2003 May;83(5):613-22
references.pmid: 12746471
references.citation: Cancer Sci. 2011 Oct;102(10):1815-21
references.pmid: 21722266
references.citation: Mol Cancer. 2005 Apr 07;4(1):14
references.pmid: 15817123
references.citation: Histopathology. 2011 May;58(6):944-52
references.pmid: 21585429
references.citation: Exp Hematol. 2002 Jan;30(1):34-41
references.pmid: 11823035
references.citation: J Biol Chem. 2012 Jan 6;287(2):1478-88
references.pmid: 22102278
references.citation: J Cell Physiol. 1998 Mar;174(3):310-21
references.pmid: 9462693
references.citation: J Biol Chem. 2014 May 30;289(22):15231-43
references.pmid: 24753252
references.citation: Invest Ophthalmol Vis Sci. 2012 Mar 21;53(3):1530-8
references.pmid: 22323467
references.citation: Hepatology. 2008 Apr;47(4):1211-22
references.pmid: 18318435
references.citation: Chem Biol. 2004 Mar;11(3):367-77
references.pmid: 15123266
references.citation: J Endocrinol. 2011 May;209(2):139-51
references.pmid: 21307119
references.citation: Oncogene. 2007 Jul 26;26(34):4969-78
references.pmid: 17310998
references.citation: Liver Int. 2010 Nov;30(10):1522-8
references.pmid: 21040406
references.citation: Mol Cancer Res. 2012 Jun;10(6):689-702
references.pmid: 22513363
references.citation: J Biol Chem. 2007 May 4;282(18):13326-33
references.pmid: 17347152
references.citation: Mol Carcinog. 2012 Jul;51(7):565-75
references.pmid: 21739484
references.citation: Oncogene. 2014 Apr 3;33(14):1799-808
references.pmid: 23644656
references.citation: Clin Biochem. 2013 Jul;46(10-11):926-32
references.pmid: 23415719
references.citation: Med Oncol. 2013 Mar;30(1):403
references.pmid: 23288725
references.citation: J Biochem. 1995 Dec;118(6):1255-60
references.pmid: 8720143
references.citation: FASEB J. 2001 Jul;15(9):1661-3
references.pmid: 11427519
references.citation: Oncol Res. 2008;17(4):183-9
references.pmid: 18773863
references.citation: Expert Opin Investig Drugs. 2008 Nov;17(11):1769-76
references.pmid: 18922112
references.citation: Glycobiology. 2010 Feb;20(2):175-86
references.pmid: 19822709
references.citation: Oncogene. 2004 Feb 19;23(7):1439-47
references.pmid: 14973553
references.citation: Cancer Res. 2011 Mar 15;71(6):2152-61
references.pmid: 21266348
references.citation: Nat Chem Biol. 2007 Dec;3(12):773-8
references.pmid: 17952066
references.citation: Mod Pathol. 2002 Jun;15(6):593-8
references.pmid: 12065771
references.citation: Oncogene. 2010 Feb 4;29(5):635-46
references.pmid: 19855436
references.citation: Br J Pharmacol. 2007 May;151(1):1-14
references.pmid: 17339837
references.citation: Anticancer Res. 2001 Sep-Oct;21(5):3365-9
references.pmid: 11848495
references.citation: J Biol Chem. 2013 Jul 19;288(29):21389-21398
references.pmid: 23740243
references.citation: Oncol Lett. 2011 Nov;2(6):1291-1295
references.pmid: 22848304
references.citation: J Biol Chem. 2003 Jun 20;278(25):23107-17
references.pmid: 12686563
references.citation: Blood. 2013 Nov 21;122(22):3666-77
references.pmid: 24113869
references.citation: Biomed Res Int. 2013;2013:852093
references.pmid: 23984412
references.citation: J Biol Chem. 2004 May 28;279(22):23536-41
references.pmid: 15044433
references.citation: Yao Xue Xue Bao. 2013 Apr;48(4):609-14
references.pmid: 23833953
references.citation: J Med Chem. 2014 Jun 12;57(11):4511-20
references.pmid: 24786387
references.citation: J Pathol. 2012 Sep;228(1):88-98
references.pmid: 22653794
references.citation: Curr Med Chem. 2006;13(18):2101-11
references.pmid: 16918340